Outcomes Associated With Rivaroxaban in Asians With End-stage Renal Disease and Atrial Fibrillation

被引:0
|
作者
Lin, Yi-Cheng
Chien, Li-Nien
Chen, Liying
Chen, Bi-Li
Fang, Te-Chao
Huang, Chun-Yao
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A11234
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Rivaroxaban-induced hemorrhagic pericardial tamponade in end-stage renal disease
    Nicole Rapista
    Sauradeep Sarkar
    Rahul Chaudhary
    [J]. Journal of Thrombosis and Thrombolysis, 2020, 50 : 982 - 983
  • [42] Does Atrial Fibrillation Increase the Risk of Developing End-stage Renal Disease in Patients with Chronic Kidney Disease?
    Suwanwongse, Kulachanya
    Shabarek, Nehad
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
  • [43] Stroke and Bleeding in Patients with Atrial Fibrillation and End-Stage Renal Disease Treated with Apixaban Versus Warfarin
    Lara, Joao Manoel Da Silveira
    Dourado, Claudia
    [J]. BLOOD, 2023, 142
  • [44] Amyloidosis and end-stage renal disease associated with leprosy
    da Silva Junior, Geraldo Bezerra
    Barbosa, Orivaldo Alves
    Barros, Roseanne de Moura
    Carvalho, Priscila dos Reis
    de Mendoza, Talita Rodrigues
    Sousa Barreto, Dulce Maria
    Barboza, Celio Araujo
    Carvalho Guimaraes, Antonio Augusto
    Daher, Elizabeth de Francesco
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2010, 43 (04) : 474 - 476
  • [45] ASCITES ASSOCIATED WITH END-STAGE RENAL-DISEASE
    GLUCK, Z
    NOLPH, KD
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 10 (01) : 9 - 18
  • [46] EVALUATION OF P WAVE INDICES AND A NOVEL PREDICTOR OF ATRIAL FIBRILLATION IN PATIENTS WITH END-STAGE RENAL DISEASE
    Solak, Y.
    Gul, E. E.
    Abdulhalikov, T.
    Atalay, H.
    Kayrak, M.
    Turk, S.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S52 - S52
  • [47] Use of Oral Anticoagulation for Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays?
    Li, Jun
    Liu, Xinyue
    Zheng, Sulin
    Huang, Yuli
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (01): : 96 - 97
  • [48] Atrial Fibrillation and Anticoagulant Treatment in End-Stage Renal Disease Patients: Where Do We Stand?
    Di Lullo, Luca
    Mariani, Marco Valerio
    Ronco, Claudio
    Bellasi, Antonio
    Lavalle, Carlo
    Chimenti, Cristina
    Paoletti, Ernesto
    Ravera, Maura
    Zanella, Monica
    [J]. CARDIORENAL MEDICINE, 2022, 12 (04) : 131 - 140
  • [49] Association between atrial fibrillation and risk of end-stage renal disease among adults with diabetes mellitus
    Chang, Yu-Kang
    Fan, Hueng-Chuen
    Lin, Chi-Chien
    Wang, Yuan-Hung
    Tsai, Wan-Ni
    Lim, Paik-Seong
    [J]. PLOS ONE, 2022, 17 (08):
  • [50] Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?
    Yalamanchili, Venkata
    Reilly, Robert F.
    [J]. SEMINARS IN DIALYSIS, 2011, 24 (04) : 387 - 388